CAPTOZYME
Biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch Nephure in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their bodies.
CAPTOZYME
Industry:
Biotechnology Fitness Health Care Therapeutics
Founded:
2009-01-01
Address:
Gainesville, Florida, United States
Country:
United States
Website Url:
http://www.captozyme.com
Total Employee:
11+
Status:
Active
Contact:
785.760.3128
Email Addresses:
[email protected]
Total Funding:
3.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator Mimecast
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.captozyme.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Captozyme"
Captozyme - Crunchbase Company Profile & Funding
Organization. Captozyme . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Captozyme is a biotechnology company focused …See details»
Captozyme - LinkedIn
Captozyme | 843 followers on LinkedIn. Creating best-in-class enzymes and live biotherapeutics through innovative research and passionate diligence. | Using sound scientific principles and …See details»
Novel Enzymes Help Kidney Stone Sufferers | Seed
Apr 9, 2020 Captozyme’s services facility arm operated in parallel with its enzyme research and development arm. ... a microbiome contract development and manufacturing organization. At the end of 2019, ArrantaBio purchased …See details»
Captozyme Company Profile 2024: Valuation, Investors …
Captozyme has raised $3.4M. Who are Captozyme’s investors? Institute for Commercialization of Florida Technology , National Center For Complementary And Integrative Health, National Institute of Diabetes and Digestive and …See details»
Captozyme - Company Profile & Staff Directory - ContactOut
Using sound scientific principles and expert knowledge to advance the standard of care Captozyme is a leader in health care for and through the gut using novel enzymes and live …See details»
Captozyme - Products, Competitors, Financials, Employees, …
The technologies and assets were spun out from an originator company, Captozyme, Inc., in 2019 as part of a separate transaction, the acquisition of Captozyme, a process development …See details»
Captozyme: Contact Details and Business Profile - RocketReach
Captozyme is a Biotechnology, Biotechnology Research, and Enzymes company located in Gainesville, Florida with $13.80 Million in revenue and 5 employees. Find top employees, …See details»
Novel enzymes Help Kidney Stone Sufferers - National Institutes …
Apr 9, 2020 It was the services facility arm of Captozyme that ultimately attracted ArrantaBio, a microbiome contract development and manufacturing organization. At the end of 2019, …See details»
Captozyme Overview | SignalHire Company Profile
Captozyme is a private company that has been in the industry for 14 years. The company currently specializes in the Biotechnology area. ... Organization Website: captozyme.com : …See details»
Captozyme - Ownership and Business Overview - Mergr
Nov 13, 2019 Captozyme is headquartered in Gainesville, Florida. What sector is Captozyme in? Captozyme is a life science company. When was Captozyme founded? Captozyme was …See details»
Captozyme - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Captozyme is a biotechnology company focused on therapeutic enzyme-based products for health and wellness.See details»
Captozyme - Company Profile - Tracxn
Nov 19, 2024 Captozyme ranks 57th among 95 active competitors. 34 of its competitors are funded while 23 have exited. Overall, Captozyme and its competitors have raised over $2.78B …See details»
Arranta Bio announces the acquisition of Captozyme™, creating a …
Nov 13, 2019 Captozyme â„¢ was founded by Dr. Qing-Shan Li and Dr. Aaron Cowley in 2009. About Ampersand Capital Partners Founded in 1988, Ampersand is a middle market private …See details»
Captozyme - Contacts, Employees, Board Members, Advisors
Organization. Captozyme . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 4. ...See details»
Captozyme, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Captozyme, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Technology Platform:Enzyme, Drug:CZ-2294(Captozyme, Inc.), CZ …See details»
Arranta Bio announces the acquisition of Captozyme™, creating a …
Nov 15, 2019 Arranta Bio ("Arranta") announced today the acquisition of Captozymeâ„¢, and with it the establishment of Arranta's Center of Excellence for process and analytical development …See details»
Novel Enzymes Help Kidney Stone Sufferers - seed.nih.gov
Jun 28, 2024 11 April, 2020 The 13-year Human Genome Project was an amazing scientific milestone that cracked most of our genetic code. Today, we can map genomes faster and moreSee details»
Arranta Bio Announces the Acquisition of Captozyme ... - UF …
Nov 13, 2019 Arranta Bio, a contract development and manufacturing organization (CDMO), announced the acquisition of UF Innovate alumni startup Captozyme â„¢, a leader in health …See details»
Captozyme - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Captozyme . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 1. obfuscated. Total Funding …See details»
SBIR-STTR-Success: Novel Enzymes Help Kidney Stone Sufferers
Jun 23, 2022 Captozyme participated in the 2015-2016 NIH Small Business Commercial Assistance Program, designed to help NIH Small Business Program Phase II awardees …See details»